Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxalt plus Caffeine in Acute Migraine
NCT00471952Phase 3Completed
- Sponsor
- Diamond Headache Clinic
- Start
- Apr 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of caffeine in migraine (3 arms), sponsored by Diamond Headache Clinic. Primary endpoint: Percentage of migraine attacks that produce pain free response at 2 hours. Started Apr 2007; status: completed.
02
Drugs
caffeine
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00471952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00471952.